5 Results for "

GPR17 antagonist 1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "GPR17 antagonist 1" in MCE Product Catalog:

Cat. No.: HY-170589
CAS No.: 1574405-61-0
Research Areas:  

Neurological Disease

GPR17 antagonist 1 (compound 978) is a GPR17 antagonist. GPR17 antagonist 1 can be used in the study of diabetes and obesity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19638A
CAS No.: 163706-36-3
Synonyms: AR-C69931MX tetrasodium
Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist .
loading...
    loading...
Cat. No.: HY-146486
CAS No.: 2395016-49-4
Purity:  98.09%
Target:  

P2Y Receptor

Research Areas:  

Inflammation/Immunology

P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist with IC50 values of 3.17 µM and 1.67 µM against P2Y2R and GPR17, respectively. P2Y2R/GPR17 antagonist 1 shows excellent metabolic stability in human liver microsomes .
loading...
    loading...
Cat. No.: HY-19638
CAS No.: 163706-06-7
Synonyms: AR-C69931MX
Cangrelor (AR-C69931MX), an adenosine triphosphate analogue, is an intravenous, reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor is also a nonspecific GPR17 antagonist .
loading...
    loading...
Cat. No.: HY-19638AR
CAS No.: 163706-36-3
Synonyms: AR-C69931MX tetrasodium (Standard)
Cangrelor (tetrasodium) (Standard) is the analytical standard of Cangrelor (tetrasodium). This product is intended for research and analytical applications. Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist .
loading...
    loading...